Epidemiology and clinical course of heart failure with preserved ejection fraction
Global trends in the incidence, prevalence, and years lived with disability of Parkinsons disease in 204 countries/territories from 1990 to 2019
Toki S, Goleniewska K, Reiss S, Zhang J, Bloodworth MH, Stier MT, et al
We offer two types of GLP-1 medications, semaglutide and tirzepatide
The most significant recent finding: a May 2026 Lancet randomized controlled trial (108 patients, 26 weeks) found semaglutide 2.4 mg reduced heavy drinking days by 41.1 percentage points versus 26.4 on placebo, a statistically significant 13.7-point difference
If you want to understand: why progress plateaus why GH peptides feel inconsistent and how to align peptides with performance goals Start with the Muscle, Performance & Body Composition Blueprint